Effects of Tegoprazan, Potassium-Competitive Acid Blocker, on the Gastric Emptying and Postprandial Symptoms in Healthy Humans
Digestive Diseases and Sciences · 2025
DOI: 10.1007/s10620-024-08714-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Hyung Seok Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-Gu, Seoul, 07985, Republic of Korea. Hauptthemen laut MEDLINE: Gastric Emptying, Postprandial Period, Proton Pump Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Proton pump inhibitors are potent gastric acid inhibitors. However, they may worsen symptoms such as postprandial fullness and early satiation by reducing gastric emptying (GE). This study aims to evaluate the effects of tegoprazan, a new potassium-competitive acid blocker, on GE and dyspeptic symptoms.
Methods
A randomized, double-blind, placebo-controlled design was adopted for this study. Participants underwent GE tests and responded to a questionnaire regarding gastrointestinal symptoms before and after administration of tegoprazan 50 mg. GE was assessed using scintigraphy over 4 h with a standardized solid meal.
Results
Thirty participants were recruited (19 men, mean age 28.2 ± 7.3 years). After medication, no significant differences were observed in gastric half emptying time (T 1/2 ) and gastric retention at 4 h (GE 4 h) between the tegoprazan and the control group (114.2 ± 48.9 min vs. 93.7 ± 34.7 min, P = 0.20; 10.1 ± 12.0% vs. 4.3 ± 5.4%, P = 0.11, respectively). Furthermore, there were no statistically significant differences detected in the changes within each group between two groups (T 1/2 , 9.9 ± 52.7 min vs. − 4.7 ± 30.5 min, P = 0.36; GE 4 h, 5.2 ± 13.9% vs. − 1.3 ± 6.5%, P = 0.12). The changes in dyspeptic symptom scores after tegoprazan administration did not significantly differ from those in the control group with no correlation between symptoms and GE parameters.
Conclusions
In healthy adults, the administration of tegoprazan did not show a significant impact on GE and dyspeptic symptoms, especially postprandial fullness or early satiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-Gu, Seoul, 07985, Republic of Korea.
- Department of Nuclear Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.
- Department of Internal Medicine, College of Medicine, Ewha Womans University, 1071 Anyangcheon-Ro, Yangcheon-Gu, Seoul, 07985, Republic of Korea. junghk@ewha.ac.kr.
- Department of Internal Medicine, College of Medicine, Inha University, Incheon, Korea.
- Department of Nuclear Medicine, College of Medicine, Inha University, Incheon, Korea.
Zitieren
APA
Lim, H. S., Yoon, H. J., Jung, H. K., Hong, J. T., Yoo, M. Y., & Jeong, E. S. (2025). Effects of Tegoprazan, Potassium-Competitive Acid Blocker, on the Gastric Emptying and Postprandial Symptoms in Healthy Humans. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08714-0
Vancouver
Lim HS, Yoon HJ, Jung HK, Hong JT, Yoo MY, Jeong ES. Effects of Tegoprazan, Potassium-Competitive Acid Blocker, on the Gastric Emptying and Postprandial Symptoms in Healthy Humans. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-024-08714-0
BibTeX
@article{Lim2025,
author = {Lim, Hyung Seok and Yoon, Hai-Jeon and Jung, Hye-Kyung and Hong, Ji Taek and Yoo, Min Young and Jeong, Eui Sun},
title = {Effects of Tegoprazan, Potassium-Competitive Acid Blocker, on the Gastric Emptying and Postprandial Symptoms in Healthy Humans},
journal = {Digestive Diseases and Sciences},
year = {2025},
doi = {10.1007/s10620-024-08714-0}
}
EUVIMED